Maayan Eilon-Ashkenazy - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Nature Communications|August 21, 2024

The structure of the Lujo virus spike complexMaayan Eilon-Ashkenazy, Hadas Cohen-Dvashi, Sarah Borni, et al.

Nature|February 17, 2022

Structure and receptor recognition by the Lassa virus spike complexMichael Katz, Jonathan Weinstein, Maayan Eilon-Ashkenazy, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|October 25, 2023

Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarctionAmit Itzhar, Gal Yosef, Maayan Eilon-Ashkenazy, et al.

Iscience|October 3, 2022

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concernHadas Cohen-Dvashi, Jonathan Weinstein, Michael Katz, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Nature Communications|August 21, 2024

The structure of the Lujo virus spike complexMaayan Eilon-Ashkenazy, Hadas Cohen-Dvashi, Sarah Borni, et al.

Nature|February 17, 2022

Structure and receptor recognition by the Lassa virus spike complexMichael Katz, Jonathan Weinstein, Maayan Eilon-Ashkenazy, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|October 25, 2023

Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarctionAmit Itzhar, Gal Yosef, Maayan Eilon-Ashkenazy, et al.

Iscience|October 3, 2022

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concernHadas Cohen-Dvashi, Jonathan Weinstein, Michael Katz, et al.

Pageof 1